These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8105857)

  • 1. Deletion mutagenesis of rat PC12 tyrosine hydroxylase regulatory and catalytic domains.
    Ribeiro P; Wang Y; Citron BA; Kaufman S
    J Mol Neurosci; 1993; 4(2):125-39. PubMed ID: 8105857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic core of rat tyrosine hydroxylase: terminal deletion analysis of bacterially expressed enzyme.
    Walker SJ; Liu X; Roskoski R; Vrana KE
    Biochim Biophys Acta; 1994 May; 1206(1):113-9. PubMed ID: 7910484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and characterization of catalytic and regulatory domains of rat tyrosine hydroxylase.
    Daubner SC; Lohse DL; Fitzpatrick PF
    Protein Sci; 1993 Sep; 2(9):1452-60. PubMed ID: 8104613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of chimeric pterin-dependent hydroxylases: contributions of the regulatory domains of tyrosine and phenylalanine hydroxylase to substrate specificity.
    Daubner SC; Hillas PJ; Fitzpatrick PF
    Biochemistry; 1997 Sep; 36(39):11574-82. PubMed ID: 9305947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion mutagenesis of human tyrosine hydroxylase type 1 regulatory domain.
    Ota A; Yoshida S; Nagatsu T
    Biochem Biophys Res Commun; 1995 Aug; 213(3):1099-106. PubMed ID: 7654226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low affinity dopamine binding site on tyrosine hydroxylase: the role of the N-terminus and in situ regulation of enzyme activity.
    Gordon SL; Webb JK; Shehadeh J; Dunkley PR; Dickson PW
    Neurochem Res; 2009 Oct; 34(10):1830-7. PubMed ID: 19448984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic domain surface residues mediating catecholamine inhibition in tyrosine hydroxylase.
    Briggs GD; Bulley J; Dickson PW
    J Biochem; 2014 Mar; 155(3):183-93. PubMed ID: 24334288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion mutants of tyrosine hydroxylase identify a region critical for heparin binding.
    Daubner SC; Piper MM
    Protein Sci; 1995 Mar; 4(3):538-41. PubMed ID: 7795535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level expression of rat PC12 tyrosine hydroxylase cDNA in Escherichia coli: purification and characterization of the cloned enzyme.
    Wang YH; Citron BA; Ribeiro P; Kaufman S
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8779-83. PubMed ID: 1681542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine inhibition of human tyrosine hydroxylase type 1 is controlled by the specific portion in the N-terminus of the enzyme.
    Nakashima A; Mori K; Suzuki T; Kurita H; Otani M; Nagatsu T; Ota A
    J Neurochem; 1999 May; 72(5):2145-53. PubMed ID: 10217296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric tyrosine/tryptophan hydroxylase. The tyrosine hydroxylase regulatory domain serves to stabilize enzyme activity.
    Mockus SM; Kumer SC; Vrana KE
    J Mol Neurosci; 1997 Aug; 9(1):35-48. PubMed ID: 9356925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of a novel enzyme: tyrosine hydroxylase from Schistosoma japonicum.
    Hu Y; Shi D; Luo Q; Liu Q; Zhou Y; Liu L; Yu L; Wei W; Shen J
    Parasitol Res; 2011 Oct; 109(4):1065-74. PubMed ID: 21556690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of N-terminus-deleted human tyrosine hydroxylase type 1 by end products of catecholamine biosynthetic pathway.
    Ota A; Yoshida S; Nagatsu T
    J Neural Transm (Vienna); 1996; 103(12):1415-28. PubMed ID: 9029408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and deletion mutagenesis of tryptophan hydroxylase fusion proteins: delineation of the enzyme catalytic core.
    D'Sa CM; Arthur RE; Kuhn DM
    J Neurochem; 1996 Sep; 67(3):917-26. PubMed ID: 8752096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of recombinant rat tyrosine hydroxylase by dopamine.
    Ribeiro P; Wang Y; Citron BA; Kaufman S
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9593-7. PubMed ID: 1357665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dopamine on N-terminus-deleted human tyrosine hydroxylase type 1 expressed in Escherichia coli.
    Ota A; Nakashima A; Mori K; Nagatsu T
    Neurosci Lett; 1997 Jun; 229(1):57-60. PubMed ID: 9224801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of a novel form of tyrosine hydroxylase from the human parasite, Schistosoma mansoni.
    Hamdan FF; Ribeiro P
    J Neurochem; 1998 Oct; 71(4):1369-80. PubMed ID: 9751167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A carboxyl terminal leucine zipper is required for tyrosine hydroxylase tetramer formation.
    Vrana KE; Walker SJ; Rucker P; Liu X
    J Neurochem; 1994 Dec; 63(6):2014-20. PubMed ID: 7964718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: effects on enzyme stability and activity.
    Royo M; Fitzpatrick PF; Daubner SC
    Arch Biochem Biophys; 2005 Feb; 434(2):266-74. PubMed ID: 15639226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase.
    Xu Y; Stokes AH; Roskoski R; Vrana KE
    J Neurosci Res; 1998 Dec; 54(5):691-7. PubMed ID: 9843160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.